Home/Filings/4/0001104659-21-053166
4//SEC Filing

Shapiro Aron 4

Accession 0001104659-21-053166

CIK 0001372514other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 4:15 PM ET

Size

5.6 KB

Accession

0001104659-21-053166

Insider Transaction Report

Form 4
Period: 2021-04-19
Shapiro Aron
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-19+4,0004,000 total
    Exercise: $4.40Exp: 2031-04-19Common Stock (4,000 underlying)
Footnotes (1)
  • [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 19, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1
  • filerCIK 0001855207

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:15 PM ET
Size
5.6 KB